Shares of Dentsply Sirona Inc. (XRAY) plummeted in pre-market trading on Wednesday, falling as much as 5.13% after the dental products giant slashed its full-year revenue and earnings guidance for 2024.
While Dentsply Sirona reported better-than-expected third-quarter earnings of $0.50 per share, topping analysts' estimates of $0.47, the company lowered its outlook for the full fiscal year, citing several headwinds.
For 2024, Dentsply Sirona now expects net sales in the range of $3.79 billion to $3.83 billion, down from its previous guidance of $3.86 billion to $3.90 billion. The company also cut its adjusted earnings per share forecast to $1.82 to $1.86, compared to the earlier range of $1.96 to $2.02.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.